• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Tulin Budak-Alpdogan, Demirçay, +7 authors T. Akoǧlu
  • Medicine
  • British journal of rheumatology
  • 1998 (First Publication: 1 November 1998)
  • Typical manifestations of Behcet's disease (BD) and a positive pathergy reaction were observed in a few patients with chronic myeloid leukaemia (CML) on interferon alpha (IFN-alpha) therapy and theContinue Reading
  • Tulin Budak-Alpdogan, Mark Przybylowski, Mithat Gonen, Michel Sadelain, Joseph Bertino, Isabelle Riviére
  • Biology, Medicine
  • Human gene therapy
  • 2006 (First Publication: 30 June 2006)
  • The successful transduction and engraftment of human mobilized peripheral blood (MBP) CD34(+) cells are determined to a large extent by the ex vivo cell-processing conditions. In preparation forContinue Reading
  • Onder Alpdogan, Tulin Budak-Alpdogan, +5 authors T. Akoǧlu
  • Medicine
  • British journal of haematology
  • 1998 (First Publication: 1 December 1998)
  • Fifty-seven adult patients with idiopathic thrombocytopenic purpura (ITP) were treated with either conventional-dose prednisolone (CDP) (1 mg/kg/d, 36 patients) or high-dose methylprednisolone (HDP)Continue Reading
  • Tulin Budak-Alpdogan, Onder Alpdogan, Debabrata Banerjee, Eunice Hsiao-hui Wang, Malcolm A. S. Moore, Joseph R. Bertino
  • Biology, Medicine
  • Molecular therapy : the journal of the American…
  • 2004 (First Publication: 1 September 2004)
  • An SFG-based retroviral bicistronic vector containing a double-mutant dihydrofolate reductase-cytidine deaminase fusion cDNA (F/S DHFR-CD) with IRES-eGFP confers resistance to both methotrexate (MTX)Continue Reading
  • Gina M Capiaux, Tulin Budak-Alpdogan, +4 authors Joseph R. Bertino
  • Biology, Medicine
  • Human gene therapy
  • 2003 (First Publication: 20 March 2003)
  • Gene transfer-based myeloprotection strategies against chemotherapy require the development of effective drug resistance genes or gene combinations. Our laboratory has previously generatedContinue Reading